Atricure, Inc.
Clinical trials sponsored by Atricure, Inc., explained in plain language.
-
New hybrid heart procedure aims to tame stubborn AFib
Disease control OngoingThis study looks at a procedure called hybrid convergent ablation for people with a long-lasting type of irregular heartbeat (atrial fibrillation) that hasn't improved with medication. The procedure uses heat energy to destroy heart tissue causing the problem, combining a small c…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Heart pouch closure during surgery may slash stroke risk
Prevention OngoingThis study tests whether closing a small pouch in the heart (the left atrial appendage) during heart surgery can prevent strokes and blood clots. About 6,500 adults at risk for atrial fibrillation and stroke are taking part. The goal is to see if this simple addition to surgery i…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
New heart procedure aims to tame racing heartbeat without drugs
Symptom relief OngoingThis study tests a hybrid surgical ablation procedure for people with inappropriate sinus tachycardia (IST), a condition where the heart beats too fast without a clear cause. The procedure uses a device to carefully target heart tissue while sparing the sinus node. Researchers wa…
Phase: NA • Sponsor: AtriCure, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC